ArticleTransplant international : official journal of the European Society for Organ Transplantation2022

Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy.

Antoine Morel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.